Thoratec Corp. hopes to establish less invasive approaches for implanting its ventricular-assist devices with technology acquired in its acquisition of Galway, Ireland-based Apica Cardiovascular Ltd.
Thoratec announced the deal July 2, including a $35 million upfront cash payment plus up to $40 million in future...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?